Finally, piR-34736 (DQ596670), upregulated by 2-fold in TCGA HNSCCs and correlated to patient survival and PRDM9 mutation (Figure 3A, 3D), was recently observed to be downregulated in breast cancers, with uncharacterized functional significance [18]. This evidence concerns the gene PIR and breast cancer.